Cambridge Healthtech Institute’s 2nd Annual

Women’s Health Venture and Innovation

Building the Women's Health Economy

April 12-13, 2027

Investment in women’s health is accelerating, driven by growing recognition of both the unmet needs and significant market opportunities across the sector. Yet despite recent progress, women’s health remains underfunded relative to its impact, creating substantial opportunities for innovation, company creation, and value generation. CHI’s 2nd Annual Women’s Health Venture and Innovation conference brings together investors, entrepreneurs, corporate strategics, healthcare leaders, and innovators to explore the trends, technologies, and business models shaping the future of women’s health. Through discussions on investment, commercialization, partnerships, market access, and emerging innovations across FemTech, MedTech, diagnostics, digital health, and AI, attendees will gain insights into the opportunities and challenges driving this rapidly evolving market. Join the leaders, founders, and investors building the next generation of women’s health companies and defining the future of the women’s health economy.

Coverage will include, but is not limited to:

The Women's Health Investment Landscape
Capital Formation & Venture Investing
Emerging Technologies & Innovation Trends
Investing Across the Women's Health Lifecycle
Startup Growth, Scale-Up, & Commercialization
Market Access, Reimbursement, & Adoption
Strategic Partnerships, Corporate Venture, & M&A

The deadline for priority consideration is September 11, 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: